Bruker and the Champalimaud Foundation to develop first 18 Tesla UHF MR scanner

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

Study advises personalized breast cancer screenings for cancer survivors May benefit from MR alone, rather than MR and mammography

Knitting raises thousands for Scottish MR scanner fundraising campaign Improving access to care in remote Shetland Islands

CT and MR waiting times costing Canadians over $3 billion Need $4.4 billion to update imaging stock, says report

MR and ultrasound biopsies combined can detect prostate cancers, says study Detect up to 33 percent more tumors together

Demand on the rise for MR-guided radiotherapy, says new report Compound annual growth rate of 20 percent through 2028

Breast MR for cancer survivors may result in unnecessary biopsies No difference in sensitivity compared to mammography alone

SEC probes Siemens, GE and Philips over business with China Lawsuit alleges OEMs worked together to fix prices on medical equipment

Ezra launches direct-to-consumer full-body MR scanning program Full-body imaging for $1,950 or single-region starting at $675

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Whole body MR may support faster, less expensive cancer treatment planning A single scan for planning and staging, but challenges remain

Bruker and the Champalimaud Foundation
are developing the first 18 Tesla
11 cm bore, preclinical ultra-high
field MR system

Bruker and the Champalimaud Foundation to develop first 18 Tesla UHF MR scanner

por John R. Fischer , Staff Reporter
Bruker has teamed up with the Champalimaud Foundation, a biomedical research foundation in Portugal, to develop the first 18 Tesla 11 cm bore, preclinical ultra-high-field MR (UHF MR) system and its clinical research applications.

Announced at the Annual Meeting of the International Society for Magnetic Resonance in Medicine, the solution is expected to advance research endeavors at Champalimaud around translational cancer and neuroscience through the use of UHF MR and magnetic resonance spectroscopic imaging.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"We are very excited to explore the full potential of the 18T MR system, and to advance our understanding of biological mechanisms underlying healthy and diseased conditions,” Dr. Noam Shemesh, principal investigator at the Champalimaud Foundation, said in a statement. “We intend to harness the 18T ultra-high-field and enhanced sensitivity to facilitate investigations into microstructure and metabolism dynamics in the brain, as well as in cancer, highlighting MR as a tool for answering fundamental questions in biology, and not 'just' as a powerful diagnostic tool.”

The aim behind using 18T MR is to improve clinical outcomes through the development of new spatially-resolved contrast mechanisms for elucidating biological function with MR and spectroscopic imaging, as well as enhance temporal resolution for retrieving additional information on brain dynamics.

The system is expected to advance in vivo research at the Champalimaud Foundation for cancer, metastasis, and pre-metastatic niches (PMNs) in multiple cancer models. It also will be implemented in the study of brain plasticity and activity in normal and neurodegenerative disease models.

"We are extremely pleased to partner with the Champalimaud Foundation to collaborate on unique, enabling research tools to advance scientific research in both neuroscience and oncology,” said Dr. Wulf-Ingo Jung, president of Bruker's preclinical imaging division, in a statement. “This exciting UHF MR partnership will be a demonstration of what can be achieved in collaboration with a leading medical research institution."

Development of the 18 Tesla MR scanner comes a year and half after the installation of Bruker’s 15.2 Tesla MR system at The Weizmann Institute of Science in Israel, and months after energizing the world's first stable and homogeneous standard-bore Ascend 1.1 GHz NMR magnet in late 2018.

The system is expected to be installed in late 2021 in the Foundation’s Neuroplasticity and Neural Activity laboratory.

Bruker did not respond for comment.

MRI Homepage


You Must Be Logged In To Post A Comment